European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma

European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma

Ads

You May Also Like

Stemline Therapeutics Presents SL-801 Phase 1 Data at ESMO 2017

NEW YORK, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

AngioSoma, Inc. Announces Grant of Patent for Flagship Drug

HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to ...